The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Continued Response Following Treatment with IMC-C225, an EGFr MoAb, Combined with RT in Advanced Head and Neck Malignancies.
 
Emily Ko
Employment - Elsevier (I)
Honoraria - Brigham and Women's Hospital
Research Funding - Bristow Myers Squibb; Faeth Therapeutics (Inst); Foundation for Women's Cancer; Ovarian Cancer Research Alliance; Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - Brigham and Women's Hospital; Virginia Commonwealth University
 
Lakeisha Mulugeta-Gordon
No Relationships to Disclose
 
Christine Pae
No Relationships to Disclose
 
Destiny Uwawaike
No Relationships to Disclose
 
Katie Elkins
No Relationships to Disclose
 
Jesse Chittams
No Relationships to Disclose
 
Nehemiah Weldeab
No Relationships to Disclose
 
Lee Ang
No Relationships to Disclose
 
Anna Jo Smith
Research Funding - GlaxoSmithKline
 
Carmen Guerra
Stock and Other Ownership Interests - BEAM Therapeutics; crispr therapeutics; Editas Medicine; Intellia Therapeutics
Honoraria - National Comprehensive Cancer Network
Consulting or Advisory Role - Guardant Health; Janssen (I); Natera; Roche
Speakers' Bureau - Janssen (I)
Research Funding - Genentech (Inst)
Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.
 
Andrea Bilger
No Relationships to Disclose